Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myelomaIbai Goicoechea(Navarre Institute of Health Research), Bruno Paiva(Navarre Institute of Health Research)BloodJuly 21, 202010.1182/blood.2020006731Cited by 130SaveCiteExport RISWatch citationsRelated PapersCirculating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma|Leukemia|2020|47